Display options
Share it on

Plants (Basel). 2021 Oct 23;10(11). doi: 10.3390/plants10112273.

Bromelain Extract Exerts Antiarthritic Effects via Chondroprotection and the Suppression of TNF-α-Induced NF-κB and MAPK Signaling.

Plants (Basel, Switzerland)

Peraphan Pothacharoen, Rujirek Chaiwongsa, Theerawut Chanmee, Orapin Insuan, Thanchanok Wongwichai, Phornpimon Janchai, Pilanee Vaithanomsat

Affiliations

  1. Thailand Excellence Center for Tissue Engineering and Stem Cells, Department of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.
  2. Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand.
  3. Department of Clinical Chemistry, Faculty of Medical Technology, Mahidol University, Nakhon Pathom 73170, Thailand.
  4. Department of Medical Technology, School of Allied Health Sciences, University of Phayao, Phayao 56000, Thailand.
  5. Unit of Excellence in Integrative Molecular Biomedicine, School of Allied Health Sciences, University of Phayao, Phayao 56000, Thailand.
  6. Nanotechnology and Biotechnology Research Division, Kasetsart Agricultural and Agro-Industrial Product Improvement Institute (KAPI), Kasetsart University, Bangkok 10900, Thailand.
  7. Center for Advanced Studies in Tropical Natural Resources, National Research University-Kasetsart University, Kasetsart University, Bangkok 10900, Thailand.

PMID: 34834636 PMCID: PMC8625807 DOI: 10.3390/plants10112273

Abstract

Bromelain, a mixture of proteases in pineapple rhizome, has beneficial biological properties. Following absorption, the compound remains biologically active in mammalian blood and tissues. Bromelain has multiple clinical and therapeutic applications because of its anti-arthritic activities. Anti-inflammation is one of the putative therapeutic effects of bromelain on osteoarthritis (OA) and rheumatoid arthritis (RA), but the molecular mechanisms in cartilage and synovial fibroblast has not been reported. Thus, in this study, interleukin (IL)-1β/oncostatin M-induced porcine cartilage and TNF-α-induced synovial fibroblast were used as the inflamed OA and RA models, respectively. The results demonstrated the chondroprotective effects of bromelain on cartilage degradation and the downregulation of inflammatory cytokine (tumor necrosis factor (TNF)-α, IL-1β, IL-6, IL-8) expression in TNF-α-induced synovial fibroblasts by suppressing NF-κB and MAPK signaling. The evidence from this study supported and explained the anti-inflammatory and analgesic effects of bromelain on arthritis in animal models and clinical studies.

Keywords: anti-arthritis; anti-inflammation; bromelain; chondroprotection; osteoarthritis; rheumatoid arthritis

References

  1. Oncol Rep. 1999 Nov-Dec;6(6):1191-9 - PubMed
  2. Clin Exp Immunol. 1991 Dec;86(3):380-6 - PubMed
  3. Life (Basel). 2021 Apr 06;11(4): - PubMed
  4. Connect Tissue Res. 2018 Jul;59(4):316-331 - PubMed
  5. Nutr J. 2016 Jan 05;15:1 - PubMed
  6. Inflamm Res. 1995 May;44(5):217-21 - PubMed
  7. Indian J Med Res. 2014 Jan;139(1):117-24 - PubMed
  8. Rheumatology (Oxford). 2006 Jun;45(6):669-75 - PubMed
  9. Biopharm Drug Dispos. 1988 Jul-Aug;9(4):397-403 - PubMed
  10. Pa Med J. 1964 Jun;67:27-30 - PubMed
  11. J Assoc Physicians India. 2001 Jun;49:617-21 - PubMed
  12. Cell Death Differ. 2003 Jan;10(1):45-65 - PubMed
  13. Clin Immunol. 2008 Mar;126(3):345-52 - PubMed
  14. Evid Based Complement Alternat Med. 2012;2012:548486 - PubMed
  15. Biotechnol Res Int. 2012;2012:976203 - PubMed
  16. Front Immunol. 2017 Nov 10;8:1468 - PubMed
  17. Biochim Biophys Acta. 1990 May 22;1052(3):366-78 - PubMed
  18. J Immunol. 2001 Feb 15;166(4):2705-11 - PubMed
  19. Evid Based Complement Alternat Med. 2004 Dec;1(3):251-257 - PubMed
  20. Curr Issues Mol Biol. 2021 May 07;43(1):93-106 - PubMed
  21. Biomed Pharmacother. 2019 Apr;112:108610 - PubMed
  22. Clin Rheumatol. 2004 Oct;23(5):410-5 - PubMed
  23. Arthritis Rheum. 2000 Apr;43(4):801-11 - PubMed
  24. Int J Immunopathol Pharmacol. 2021 Jan-Dec;35:20587384211034686 - PubMed
  25. Am J Physiol. 1997 Jul;273(1 Pt 1):G139-46 - PubMed
  26. Mediators Inflamm. 2014;2014:561459 - PubMed
  27. BMC Complement Altern Med. 2017 Dec 13;17(1):532 - PubMed
  28. Arthritis Res Ther. 2009;11(3):224 - PubMed
  29. Lancet. 1989 Jul 29;2(8657):244-7 - PubMed
  30. Eur J Immunol. 1991 Oct;21(10):2575-9 - PubMed
  31. Farmaco Prat. 1972 Aug;27(8):453-66 - PubMed
  32. Phytomedicine. 2002 Dec;9(8):681-6 - PubMed
  33. Clin Orthop Relat Res. 2001 Oct;(391 Suppl):S61-71 - PubMed
  34. Eur Cytokine Netw. 1995 Jul-Dec;6(4):225-30 - PubMed
  35. In Vitro Cell Dev Biol Anim. 2003 Sep-Oct;39(8-9):337-9 - PubMed
  36. J Clin Invest. 2008 Nov;118(11):3537-45 - PubMed
  37. N Engl J Med. 2001 Mar 22;344(12):907-16 - PubMed
  38. Ann Rheum Dis. 2000 Nov;59 Suppl 1:i75-80 - PubMed
  39. Immunol Invest. 2008;37(4):263-77 - PubMed
  40. J Agric Food Chem. 2006 Mar 22;54(6):2193-8 - PubMed
  41. Ann Rheum Dis. 2002 Aug;61(8):704-13 - PubMed
  42. Biomed Rep. 2016 Sep;5(3):283-288 - PubMed
  43. Eur J Pharmacol. 1988 Jun 10;150(3):295-301 - PubMed
  44. Cancer Lett. 2003 Feb 20;190(2):151-6 - PubMed
  45. Biorheology. 2002;39(1-2):237-46 - PubMed
  46. Cell Mol Life Sci. 2001 Aug;58(9):1234-45 - PubMed
  47. Osteoarthritis Cartilage. 2001 Aug;9(6):539-52 - PubMed
  48. Phytochemistry. 2012 Aug;80:77-88 - PubMed
  49. ISRN Inflamm. 2013 Dec 08;2013:512103 - PubMed
  50. J Pharmacol Toxicol Methods. 2015 May-Jun;73:1-6 - PubMed
  51. PLoS One. 2017 Aug 14;12(8):e0182923 - PubMed
  52. Pharmacology. 2002 May;65(2):83-6 - PubMed
  53. Rheumatology (Oxford). 2008 May;47(5):584-90 - PubMed
  54. Osteoarthritis Cartilage. 2005 Aug;13(8):672-8 - PubMed

Publication Types

Grant support